BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Welcome to the 2nd Cell Therapy for Autoimmune Disease Summit\
 n\nFollowing the latest data revealing the promise of cell therapies for 
 lupus\, all eyes are on how to pave the way to develop the first curative
  treatments for autoimmune patients\n\nThe 2nd Cell Therapy for Autoimmun
 e Disease Summit returns to Philadelphia bigger and better after last yea
 r's explosive debut as the only meeting covering every aspect of bringing
  cell therapies to the autoimmune space. This is your unmissable opportun
 ity to learn the A-Zs of accelerating your candidates to be the first in 
 the market and finally bring the cure for an autoimmune indication.\n\nJo
 in 30+ trailblazers including Cartesian Therapeutics\, Bristol Myers Squi
 bb\, the University of Pennsylvania\, ImmPACT Bio and more as they unveil
  their latest clinical updates\, next-generation candidates\, novel antig
 en targets\, and translational biomarkers to turbocharge the development 
 of cell therapies for autoimmune disease.\n\nWith a brand new 2 tracked a
 genda\, hear in-depth presentations across preclinical development versus
  clinical strategy to strategically gain the insight your team needs to b
 oost your candidates among industry pioneers. This year will be the bigge
 st edition of this meeting yet as this community expands to grasp every o
 pportunity available.\n\nURLs:Website:&nbsp\;https://go.evvnt.com/2619398
 -0?pid=185Tickets:&nbsp\;https://go.evvnt.com/2619398-2?pid=185Brochure:&
 nbsp\;https://go.evvnt.com/2619398-3?pid=185\n\nPrices:Conference Only- A
 cademic Pricing: USD 2599.00\,Conference + 1 Workshop- Academic Pricing: 
 USD 3098.00\,Conference + 2 Workshops - Academic Pricing: USD 3597.00Conf
 erence Only- Solution Provider Pricing: USD 3699.00\,Conference + 1 Works
 hop- Solution Provider Pricing: USD 4398.00\,Conference + 2 Workshops- So
 lution Provider Pricing: USD 5097.00\,Conference Only- Drug Developer Pri
 cing: USD 2999.00\,Conference + 1 Workshop- Drug Developer Pricing: USD 3
 598.00\,Conference + 2 Workshops- Drug Developer Pricing: USD 4197.00\n\n
 Speakers:&nbsp\;Chris Jewell\, Chief Scientific Officer\, Cartesian Thera
 peutics\, Chris Rudulier\, Associate Director - Autoimmunity\, Intellia T
 herapeutics\, David Porter\,Director - Cell Therapy and Transplant\, Penn
  Medicine/ University of Pennsylvania\, Ellen Cahir-McFarland\, Chief Sci
 entific Officer\, Abata Therapeutics\, Fred Aslan\, President and Chief E
 xecutive Officer\, Artiva Biotherapeutics\, Inc\, Greg Deener\, Chief Exe
 cutive Officer\, iCell Gene Therapeutics\, Haig Aghajanian\, Co-Founder\,
  Vice President and Head of Research\, Capstan Therapeutics\, Isin Dalkil
 ic\, Senior Director\, Drug Discovery\, Orna Therapeutics\, Jason Damiano
 \, Chief Scientific Officer\, Appia Bio\, Jeffrey Jones\, Chief Medical O
 fficer\, Cullinan Therapeutics\, Inc\, Jennifer Bush\, Chief Operating Of
 ficer\, Artiva Biotherapeutics\, Inc\, Laurence Morel\, Professor and Cha
 ir\, UT Health San Antonio\, Marc Martinez Llordella\, Co-founder and Vic
 e President - Biology\, Quell Therapeutics\, Marko Radic\, Ph.D. Associat
 e Professor\, The University of Tennessee Health Science Center\, Marlene
  Carrasco\, Global Clinical Head Immunology Cell Therapy\, AstraZeneca\, 
 Matthew Collinson-Pautz\, Director - Preclinical and Translational Resear
 ch\, Indapta Therapeutics\, Maximilian Konig\, Director Cellular Therapy 
 Program Autoimmunity\, John Hopkins University School of Medicine\, Metin
  Kurtoglu\, CTO\, Cartesian Therapeutics\, Mike Dybbs\, Partner\, Samsara
  BioCapital\, Paolo Casali\, University of Texas Ashbel Smith Distinguish
 ed Professor\, UT Health San Antonio\, Phil Johnson\, Chief Scientific Of
 ficer\, Interius Bio\, Rachel Hourigan\, Research Analyst Lead\, Beacon\,
  Rahul Patel\, Independent Subject Matter Expert\, Richard Ransohoff\, Ve
 nture Partner\, Third Rock Ventures LLC\, Samik Basu\, Chief Scientific O
 fficer\, Cabaletta Bio\, Shivani Srivastava\, Vice President\, Global Pro
 gram Lead\, Cell Therapy Organization\, Bristol Myers Squibb\, Stefanie M
 andl\, CSO\, Indapta Therapeutics\, Stephen Waggoner\, Professor\, Cincin
 atti Children's Medical Center\, Susanne Diehl\, Global Program Head Immu
 nology\, Novartis\, Timothy Campbell\, Founder and VP of Biology\, Bristo
 l Myers Squibb\, Tom Wickham\, Chief Scientific Officer\, GentiBio\, Tony
  Arulanandam\, CEO and Founder\, Synaptimmune Therapeutics\, Yongke Zhang
 \, SCO\, IASO BioTherapeutics\n\nCategory:&nbsp\;Conferences | Science\, 
 Health and Medicine | Pharmaceuticals\n\nDate and Time:&nbsp\;2nd Decembe
 r 2024 at 8:00 am to 4th December 2024 at 5:00 pm\n\nVenue details:&nbsp\
 ;Sheraton Philadelphia Downtown\, 201 North 17th Street\, Philadelphia\, 
 Pennsylvania\, 19103\, United States\n
DTEND:20241204T170000
DTSTAMP:20260512T223120Z
DTSTART:20241202T080000
LOCATION:Sheraton Philadelphia Downtown\, 201\, North 17th Street\, Philad
 elphia\, Pennsylvania\, 19103\,
SEQUENCE:0
SUMMARY:Welcome to the 2nd Cell Therapy for Autoimmune Disease Summit\nFol
 lowing the latest data revealing the promise of cell therapies for lupus\
 , all eye...
UID:630af158-6874-47d3-b042-0ef498de2320
END:VEVENT
END:VCALENDAR